Sabrina Berti

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Ejection Fraction

Patient Reported Outcomes

Peritoneal Dialysis

Top Venues

Life (Basel, Switzerland)

JCEM case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Irene Capelli, Danilo Ribichini, Michele Provenzano, Daniele Vetrano, Valeria Aiello, Giuseppe Cianciolo, Valentina Vicennati, Alessandro Tomassetti, Ginevra Moschione, Sabrina Berti, Uberto Pagotto, Gaetano La Manna
Impact of Baseline Clinical Variables on SGLT2i's Antiproteinuric Effect in Diabetic Kidney Disease. Life (Basel, Switzerland) 13 (4) (2023)
Irene Capelli, Danilo Ribichini, Michele Provenzano, Daniele Vetrano, Valeria Aiello, Giuseppe Cianciolo, Valentina Vicennati, Alessandro Tomassetti, Ginevra Moschione, Sabrina Berti, Uberto Pagotto, Gaetano La Manna
Impact of Baseline Clinical Variables on SGLT2i's Antiproteinuric Effect in Diabetic Kidney Disease. Life (Basel, Switzerland) 13 (4) (2023)
Sabrina Berti, Elena Luppi, Marco Seri, Guido Zavatta
A New COL1A1 Mutation Associated With Type I Osteogenesis Imperfecta: Treatment Options for a Woman of Childbearing Age. JCEM case reports 1 (4) (2023)
Irene Capelli, Danilo Ribichini, Michele Provenzano, Daniele Vetrano, Valeria Aiello, Giuseppe Cianciolo, Valentina Vicennati, Alessandro Tomassetti, Ginevra Moschione, Sabrina Berti, Uberto Pagotto, Gaetano La Manna
Impact of Baseline Clinical Variables on SGLT2i's Antiproteinuric Effect in Diabetic Kidney Disease. Life (Basel, Switzerland) 13 (4) (2023)
Irene Capelli, Danilo Ribichini, Michele Provenzano, Daniele Vetrano, Valeria Aiello, Giuseppe Cianciolo, Valentina Vicennati, Alessandro Tomassetti, Ginevra Moschione, Sabrina Berti, Uberto Pagotto, Gaetano La Manna
Impact of Baseline Clinical Variables on SGLT2i's Antiproteinuric Effect in Diabetic Kidney Disease. Life (Basel, Switzerland) 13 (4) (2023)